• June 2022, Iridex Corporation received regulatory clearance to market and sell its Cyclo G6 platform for the treatment of glaucoma diseases in China by its National Medical Products Administration (NMPA). The Cyclo G6 system utilizes the company's MP3 Probe to deliver its MicroPulse TLT, providing non-incisional IOP control in a quick, effective, and safe procedure.

• April 2022, Lumibird Group launched the Capsulo Nd: YAG laser. The device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments.

• March 2021, Lumenis Ltd, the global leader in energy-based medical device company for aesthetic and ophthalmic applications, announced a partnership with the Advent Health Nicholson Center. This partnership helps create a center of excellence as a medical training program that will help physicians get large-scale education in a safe environment during the pandemic.

• March 2021, Iridex Corporation, a provider of innovative ophthalmic laser-based medical products, announced the strategic collaboration with Topcon Corporation. This collaboration will help the company's product portfolio get an advantage from Topcon's distribution network in Asia Pacific and other regions by combining Topcon's diagnostic and treatment products for glaucoma and retina customers.

• November 2020, NIDEK CO., LTD., a worldwide leader in the design and distribution of ophthalmic and lens edging equipment, announced the Mirante SLO (Scanning Laser Ophthalmoscope) model, add on to the Mirante portfolio of diagnostic multimodal imaging devices.

In this report, the Ophthalmic Lasers Market has been segmented by Type, Product Type, Application, End Use and Geography.

Ophthalmic Lasers Market, Segmentation by Type

The Ophthalmic Lasers Market has been segmented by Type into Photodisruption Lasers, Selective Laser Trabeculoplasty and Photocoagulation Lasers.

Photodisruption Lasers

This segment holds a significant market share of approximately 40-45%, primarily driven by the high volume of posterior capsulotomy and iridotomy procedures. These lasers are widely used in cataract post-surgery care and glaucoma treatment. Their ability to deliver precise tissue disruption without thermal damage makes them essential in ophthalmic surgery.

Selective Laser Trabeculoplasty (SLT)

SLT accounts for around 20-25% of the market and is increasingly preferred for intraocular pressure (IOP) reduction in patients with open-angle glaucoma. It offers a non-invasive alternative to glaucoma medications and is gaining popularity due to its repeatability, minimal side effects, and improved patient adherence.

Photocoagulation Lasers

This segment contributes approximately 30-35% of the market, fueled by rising cases of diabetic retinopathy, age-related macular degeneration (AMD), and retinal vein occlusion. These lasers are essential for retinal repair and vascular leakage control. Advances in pattern scanning laser technology have improved procedural efficiency and patient comfort.

Ophthalmic Lasers Market, Segmentation by Product Type

The Ophthalmic Lasers Market has been segmented by Product Type into Excimer Lasers, Femtosecond Lasers, Nd Yag Lasers, and Diode Lasers.

Excimer Lasers

This segment accounts for approximately 30-35% of the market, widely used in refractive surgeries such as LASIK, PRK, and LASEK. Known for their precision in corneal reshaping, these lasers have high success rates in correcting myopia, hyperopia, and astigmatism. Growing demand for vision correction procedures is a key driver of this segment.

Femtosecond Lasers

Holding a share of about 25-30%, femtosecond lasers are increasingly used in cataract surgery and corneal flap creation in LASIK. These lasers enable bladeless surgery with exceptional accuracy and safety. Rising preference for minimally invasive ophthalmic procedures and premium outcomes is boosting adoption globally.

Nd Yag Lasers

This segment contributes around 20-25% of the market and is commonly used in posterior capsulotomy and peripheral iridotomy. Nd Yag lasers offer non-invasive treatment options for managing secondary cataracts and glaucoma. Their efficiency, precision, and ability to treat delicate ocular tissues make them a critical tool in ophthalmic care.

Diode Lasers

Accounting for approximately 10-15% of the market, diode lasers are mainly used in retinal photocoagulation, glaucoma therapy, and ocular tumor treatment. They are valued for their compact size, energy efficiency, and cost-effectiveness, making them suitable for both hospital settings and mobile clinics.

Ophthalmic Lasers Market, Segmentation by Application

The Ophthalmic Lasers Market has been segmented by Application into Refractive Error, Cataract Surgery, Glaucoma Surgery and Others.

Refractive Error

This segment holds the largest share of approximately 35-40%, driven by the rising demand for vision correction procedures like LASIK, PRK, and SMILE. Ophthalmic lasers are essential in reshaping the cornea to treat myopia, hyperopia, and astigmatism. The growing prevalence of refractive disorders and increased awareness of laser eye surgery are fueling segment growth.

Cataract Surgery

Accounting for around 25-30% of the market, this segment is supported by the increasing adoption of femtosecond lasers for bladeless cataract procedures. These lasers assist in corneal incisions, capsulotomy, and lens fragmentation, improving surgical precision and outcomes. The rising elderly population and high incidence of age-related cataracts continue to drive demand.

Glaucoma Surgery

This segment contributes approximately 20-25%, with lasers such as Selective Laser Trabeculoplasty (SLT) and Nd Yag lasers being used to reduce intraocular pressure (IOP). Laser procedures offer a non-invasive alternative to medications and surgery, especially for patients with open-angle glaucoma. Growing awareness and advancements in laser-based glaucoma treatments are driving adoption.

Others

Contributing about 10-15% of the market, this segment includes applications in retinal repair, diabetic retinopathy treatment, and ocular tumor ablation. Photocoagulation and diode lasers are widely used in these areas, particularly as the incidence of diabetes-related eye diseases continues to rise globally.

Ophthalmic Lasers Market, Segmentation by End Use

The Ophthalmic Lasers Market has been segmented by End Use into Outpatient Facilities and Inpatient Facilities.

Outpatient Facilities

This segment holds the largest share of approximately 60-65%, driven by the growing number of ambulatory surgical centers (ASCs) and specialty eye clinics offering laser-based procedures. These facilities are favored for their cost-efficiency, shorter recovery times, and increasing availability of minimally invasive treatments for refractive errors, glaucoma, and retinal conditions.

Inpatient Facilities

Accounting for around 35-40% of the market, inpatient settings such as multispecialty hospitals are essential for managing complex ocular surgeries and advanced-stage eye disorders. These facilities typically house high-end ophthalmic laser systems and are preferred for patients requiring integrated care or postoperative monitoring.

Ophthalmic Lasers Market, Segmentation by Geography

In this report, the Ophthalmic Lasers Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Ophthalmic Lasers Market Share (%), by Geographical Region

North America

This region leads the global market with a share of approximately 35-40%, supported by high adoption of advanced ophthalmic laser systems, a strong presence of leading medical device manufacturers, and well-established reimbursement frameworks. The increasing incidence of age-related eye disorders and early access to innovative laser technologies continue to drive demand.

Europe

Europe accounts for around 25-30% of the market, driven by rising demand for refractive error correction, cataract procedures, and laser-based glaucoma treatments. Countries like Germany, the UK, and France are major contributors due to widespread availability of publicly funded eye care services and technologically advanced surgical units.

Asia Pacific

This region is the fastest-growing segment, holding approximately 20-25% of the market. Factors such as a large patient pool, growing prevalence of myopia and diabetes-related eye diseases, and increasing investments in healthcare infrastructure are driving growth. China, India, and Japan are key markets for ophthalmic laser adoption in both public and private sectors.

Middle East & Africa

Representing about 5-7% of the market, this region is seeing gradual growth due to improving access to specialized ophthalmic care and the expansion of private eye hospitals in Gulf countries. However, limited resources and affordability constraints in parts of Africa still pose challenges to broader adoption.

Latin America

This region contributes approximately 5-8% of the global market, with countries like Brazil and Mexico leading in terms of infrastructure development and public health initiatives for eye care. Increasing awareness of laser-based vision correction and growing access to affordable ophthalmic solutions support market expansion.